Rimonabant | m-entrepreneurship.com

Product Name :
Rimonabant

Search keywords :
Rimonabant

drugId :
null

Target Vo:
Cannabinoid CB1 receptor

Target Vo Short Name :
CB1

Moa_Name:
Cannabinoid CB1 receptor antagonists

First Approval Country :
EU

First Approval Date Filter:
2006

Origin Company_Name :
Sanofi

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Prader-Willi Syndrome

Termination Status :

China Termination Status :
Phase 3 Clinical

Highest Status:
Withdrawn

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Cyclin B1 (Ser126) Antibody
STING Antibody
ICAM1 Antibody (YA352): ICAM1 Antibody (YA352) is a non-conjugated and Rabbit origined monoclonal antibody about 58 kDa, targeting to ICAM1. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts